We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current XBIT market cap is 219.03M. The company's latest EPS is USD -1.0800 and P/E is -6.59.
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 500k | 1.53M | 1.68M | 300k | 0 |
Operating Income | -7.55M | -11.87M | -6.26M | -7.77M | -6.78M |
Net Income | -5.4M | -11.64M | -12.66M | -3.2M | -3.82M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.43M | 0 | 44M | 18.39M | 4.01M |
Operating Income | -20.22M | -29.53M | -15.6M | -23.61M | -33.46M |
Net Income | -21.14M | 668.63M | -11.22M | -17.41M | -32.9M |
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 270.8M | 266.46M | 250.83M | 246.1M | 242.12M |
Total Liabilities | 5.24M | 10.67M | 6.03M | 5.7M | 5.22M |
Total Equity | 265.56M | 255.8M | 244.81M | 240.4M | 236.91M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 44.35M | 816.88M | 353.74M | 275.18M | 246.1M |
Total Liabilities | 2.95M | 61.25M | 5.11M | 5.79M | 5.7M |
Total Equity | 41.4M | 755.63M | 348.64M | 269.39M | 240.4M |
Quarter End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -5.12M | -11.5M | -17.53M | -14.82M | -4.81M |
Investing | -161k | -243k | -59.99M | -63.89M | -6k |
Financing | N/A | N/A | N/A | N/A | N/A |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -16.54M | -18.27M | -65.15M | 69.45M | -14.82M |
Investing | -122k | 674.8M | -3.73M | -3.53M | -63.89M |
Financing | 513k | 42.1M | -409.72M | -67.01M | N/A |
Market Cap | 219.03M |
Price to Earnings Ratio | -6.59 |
Price to Sales Ratio | 54.1 |
Price to Cash Ratio | 1.38 |
Price to Book Ratio | 0.9 |
Dividend Yield | - |
Shares Outstanding | 30.46M |
Average Volume (1 week) | 39.62k |
Average Volume (1 Month) | 50.44k |
52 Week Change | 75.79% |
52 Week High | 9.96 |
52 Week Low | 3.51 |
Spread (Intraday) | 1.37 (17.12%) |
Company Name | XBiotech Inc |
Address |
5217 winnebago ln, austin, tx 78744 austin, texas 78744 |
Website | https://www.xbiotech.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions